Kyntra Bio, Inc. ( KYNB) - Key Metrics
KYNB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.32 | -$3.51 | -$4.53 | -$4.53 |
| 2025Q3 | $0.27 | $49.61 | -$0.46 | -$0.46 |
| 2025Q2 | $0.33 | -$1.88 | $3.14 | $3.13 |
| 2025Q1 | $0.03 | $0.05 | $0.03 | $0.03 |
KYNB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -0.62 |
| 2025Q3 | ? | 0.06 |
| 2025Q2 | ? | -0.70 |
| 2025Q1 | ? | 42.16 |
KYNB
Price: $7.22
52 week price:
Earnings Per Share: -12.85 USD
P/E Ratio: -0.54
Exchange: NGM
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 29.3 million